LYON, France & NEW YORK--(BUSINESS WIRE)--The MEDICREA group (Alternext Paris:FR0004178572 - ALMED,PEA-PME eligible), which specializes in the development and manufacturing of innovative surgical technologies for the treatment of spinal pathologies, announces its results for its 1st half to June 30th, 2015 as approved by the Board on September 3rd.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.
